Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic ...

Oculis announces agreement with US FDA on a Special Protocol Assessment for optic neuritis registrational trial: Zug, Switzerland Saturday, May 9, 2026, 11:00 Hrs [IST] Oculis Hol ...

Dr. Candice Maenza was in grad school studying the brain when she suddenly lost her vision and got a life-changing diagnosis.

A FATHER is preparing for the challenge of a lifetime by taking on a 100-mile bike ride to raise vital funds for his daughter ...

New post-hoc analysis of OCT scans on GCIPL and analysis of responders with improvement of 15 or 30-letter on low-contrast visual acuity (LCVA) from the Phase 2 ACUITY trial with Privosegtor, to be ...

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention ...

Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...

Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...

Nearly one million people in the United States live with multiple sclerosis, but according to Marcie Fitzgerald, that number could be much higher. She calls it the “invisible disease,” saying you ...